4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001209191-20-055909
Options or other derivatives
- President and CEO acquired 7,442,421 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Robbins Andrew R President and CEO | 2020-10-23 | Grant or award · Stock Option (Right to Buy) | +7,442,421 | 7,442,421 | D | ||
Loading xslF345X03/doc4.xml…